Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Rocuronium Bromide Injection
Status: Currently in Shortage
»Date first posted:
02/15/2023
»Therapeutic Categories: Anesthesia
Baxter Healthcare (Reverified 04/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Available | Tamarang is the application holder and Baxter is the distributor/labeler | |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Available | Tamarang is the application holder and Baxter is the distributor/labeler |
Eugia US LLC (Reverified 03/21/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 100 mg/10 mL (NDC 55150-226-10) | Available | Check wholesalers for inventory | |
| Injection, 50 mg/5 mL (NDC 55150-225-05) | Available | Check wholesalers for inventory |
Fresenius Kabi USA, LLC (Revised 04/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 63323-426-05) | Unavailable | Backordered. Next release April 2024; Check wholesalers for inventory | Delay in shipping of the drug |
| Injection, 10 mg/1 mL (NDC 63323-426-10) | Unavailable | Backordered. Next release not available at this time; Check wholesalers for inventory. | Delay in shipping of the drug |
| Injection, 10 mg/1 mL (NDC 65219-065-05) | Available | Check wholesalers for inventory. |
Hikma Pharmaceuticals USA, Inc. (Reverified 03/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Rocuronium Bromide Injection, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Available | Additional lots will be available. Product will be made available as it is released. | |
| Rocuronium Bromide Injection, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Available | Currently available. Additional product will be made available as it is released. |
Hospira, Inc., a Pfizer Company (Revised 03/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 0409-9558-05) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Injection, 10 mg/1 mL (NDC 0409-9558-49) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Injection, 10 mg/1 mL (NDC 0409-9558-10) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0409-9558-50) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
Meitheal Pharmaceuticals, Inc. (Reverified 03/20/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 71288-700-06) | Available | ||
| Injection, 10 mg/1 mL (NDC 71288-718-11) | Available |
Mylan Institutional, a Viatris Company (Reverified 04/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Available | ||
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Available |
Piramal Critical Care Inc. (Reverified 04/10/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 50 mg/5 mL (NDC 66794-228-41) | Available | ||
| Injection, 100 mg/10 mL (NDC 66794-229-41) | Available |
Sagent Pharmaceuticals (Revised 03/06/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 25021-687-05) | Available |
Sandoz Inc. (Reverified 04/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 0781-3220-95) | Available | ||
| Injection, 10 mg/1 mL (NDC 0781-3220-92) | Available |
XGen Pharmaceuticals DJB, Inc. (Reverified 02/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 50 mg/5 mL (NDC 39822-4200-2) | Available | Tamarang is the application holder and X-Gen is the distributor/labeler | |
| Injection, 100 mg/10 mL (NDC 39822-4200-6) | Available | Tamarang is the application holder and X-Gen is the distributor/labeler |